ARRY
Price
$4.41
Change
-$0.53 (-10.73%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
2.22B
40 days until earnings call
OCGN
Price
$0.64
Change
-$0.05 (-7.25%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
201.2M
29 days until earnings call
Ad is loading...

ARRY vs OCGN

Header iconARRY vs OCGN Comparison
Open Charts ARRY vs OCGNBanner chart's image
Array Technologies
Price$4.41
Change-$0.53 (-10.73%)
Volume$56.36K
Capitalization2.22B
Ocugen
Price$0.64
Change-$0.05 (-7.25%)
Volume$66.74K
Capitalization201.2M
ARRY vs OCGN Comparison Chart
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. OCGN commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Hold and OCGN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (OCGN: $0.69)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCGN’s FA Score shows that 0 FA rating(s) are green while.

  • OCGN’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 4 TA indicator(s) are bullish while OCGN’s TA Score has 5 bullish TA indicator(s).

  • ARRY’s TA Score: 4 bullish, 6 bearish.
  • OCGN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, OCGN is a better buy in the short-term than ARRY.

Price Growth

OCGN (@Biotechnology) experienced а -6.77% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

OCGN is expected to report earnings on May 02, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($2.22B) has a higher market cap than OCGN($201M). OCGN YTD gains are higher at: -14.410 vs. ARRY (-18.212). ARRY has higher annual earnings (EBITDA): 276M vs. OCGN (-52.79M). ARRY has more cash in the bank: 249M vs. OCGN (58.5M). OCGN has less debt than ARRY: OCGN (32.5M) vs ARRY (730M). ARRY has higher revenues than OCGN: ARRY (1.58B) vs OCGN (4.06M).
ARRYOCGNARRY / OCGN
Capitalization2.22B201M1,105%
EBITDA276M-52.79M-523%
Gain YTD-18.212-14.410126%
P/E Ratio26.23N/A-
Revenue1.58B4.06M38,890%
Total Cash249M58.5M426%
Total Debt730M32.5M2,246%
FUNDAMENTALS RATINGS
ARRY vs OCGN: Fundamental Ratings
ARRY
OCGN
OUTLOOK RATING
1..100
6516
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
8583
P/E GROWTH RATING
1..100
26100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OCGN's Valuation (65) in the null industry is somewhat better than the same rating for ARRY (98) in the Biotechnology industry. This means that OCGN’s stock grew somewhat faster than ARRY’s over the last 12 months.

OCGN's Profit vs Risk Rating (96) in the null industry is in the same range as ARRY (100) in the Biotechnology industry. This means that OCGN’s stock grew similarly to ARRY’s over the last 12 months.

OCGN's SMR Rating (99) in the null industry is in the same range as ARRY (100) in the Biotechnology industry. This means that OCGN’s stock grew similarly to ARRY’s over the last 12 months.

OCGN's Price Growth Rating (83) in the null industry is in the same range as ARRY (85) in the Biotechnology industry. This means that OCGN’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's P/E Growth Rating (26) in the Biotechnology industry is significantly better than the same rating for OCGN (100) in the null industry. This means that ARRY’s stock grew significantly faster than OCGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYOCGN
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 17 days ago
80%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOCQX44.61N/A
N/A
Tocqueville
FLCSX53.52N/A
N/A
Fidelity Large Cap Stock
MUIGX15.52N/A
N/A
Nationwide BNY Mellon Dyn US Core R6
SSCPX6.24N/A
N/A
Saratoga Small Capitalization I
GSMVX15.56N/A
N/A
Goldman Sachs Small/Mid Cap Value Instl

ARRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARRY has been closely correlated with SHLS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARRY jumps, then SHLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRY
1D Price
Change %
ARRY100%
+1.65%
SHLS - ARRY
66%
Closely correlated
N/A
FSLR - ARRY
61%
Loosely correlated
+1.76%
NXT - ARRY
59%
Loosely correlated
+3.32%
RUN - ARRY
57%
Loosely correlated
+4.47%
AXON - ARRY
53%
Loosely correlated
+3.18%
More